CGEM
Price
$8.74
Change
-$0.33 (-3.64%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
515.79M
63 days until earnings call
NNVC
Price
$1.50
Change
-$0.07 (-4.46%)
Updated
Jun 5, 04:57 PM (EDT)
Capitalization
23.95M
90 days until earnings call
Interact to see
Advertisement

CGEM vs NNVC

Header iconCGEM vs NNVC Comparison
Open Charts CGEM vs NNVCBanner chart's image
Cullinan Therapeutics
Price$8.74
Change-$0.33 (-3.64%)
Volume$6.83K
Capitalization515.79M
NanoViricides
Price$1.50
Change-$0.07 (-4.46%)
Volume$100
Capitalization23.95M
CGEM vs NNVC Comparison Chart
Loading...
CGEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NNVC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGEM vs. NNVC commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGEM is a Buy and NNVC is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (CGEM: $8.74 vs. NNVC: $1.49)
Brand notoriety: CGEM and NNVC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGEM: 71% vs. NNVC: 61%
Market capitalization -- CGEM: $515.79M vs. NNVC: $23.95M
CGEM [@Biotechnology] is valued at $515.79M. NNVC’s [@Biotechnology] market capitalization is $23.95M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGEM’s FA Score shows that 1 FA rating(s) are green whileNNVC’s FA Score has 0 green FA rating(s).

  • CGEM’s FA Score: 1 green, 4 red.
  • NNVC’s FA Score: 0 green, 5 red.
According to our system of comparison, CGEM is a better buy in the long-term than NNVC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGEM’s TA Score shows that 6 TA indicator(s) are bullish while NNVC’s TA Score has 5 bullish TA indicator(s).

  • CGEM’s TA Score: 6 bullish, 4 bearish.
  • NNVC’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, CGEM is a better buy in the short-term than NNVC.

Price Growth

CGEM (@Biotechnology) experienced а +0.69% price change this week, while NNVC (@Biotechnology) price change was -10.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.85%. For the same industry, the average monthly price growth was +10.46%, and the average quarterly price growth was -0.86%.

Reported Earning Dates

CGEM is expected to report earnings on Aug 07, 2025.

NNVC is expected to report earnings on Sep 03, 2025.

Industries' Descriptions

@Biotechnology (+7.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGEM($516M) has a higher market cap than NNVC($23.9M). NNVC YTD gains are higher at: 9.790 vs. CGEM (-25.534). NNVC has higher annual earnings (EBITDA): -8.59M vs. CGEM (-208.62M). CGEM has more cash in the bank: 304M vs. NNVC (3.96M). NNVC has less debt than CGEM: NNVC (1.5M) vs CGEM (1.84M). CGEM (0) and NNVC (0) have equivalent revenues.
CGEMNNVCCGEM / NNVC
Capitalization516M23.9M2,159%
EBITDA-208.62M-8.59M2,428%
Gain YTD-25.5349.790-261%
P/E RatioN/AN/A-
Revenue00-
Total Cash304M3.96M7,681%
Total Debt1.84M1.5M123%
FUNDAMENTALS RATINGS
NNVC: Fundamental Ratings
NNVC
OUTLOOK RATING
1..100
78
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CGEMNNVC
RSI
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 17 days ago
78%
Declines
ODDS (%)
Bearish Trend 23 days ago
89%
Bearish Trend 7 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CGEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NNVC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GOLF71.181.60
+2.30%
Acushnet Holdings Corp
PLL6.320.11
+1.77%
Piedmont Lithium
AEM123.611.10
+0.90%
Agnico Eagle Mines Ltd
VBTX23.99-0.19
-0.79%
Veritex Holdings
OCX2.93-0.14
-4.56%
Oncocyte Corp

CGEM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGEM has been loosely correlated with MDGL. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if CGEM jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGEM
1D Price
Change %
CGEM100%
+1.23%
MDGL - CGEM
50%
Loosely correlated
-1.79%
FATE - CGEM
45%
Loosely correlated
+4.41%
EYPT - CGEM
45%
Loosely correlated
+0.99%
GOSS - CGEM
45%
Loosely correlated
+3.28%
DNLI - CGEM
45%
Loosely correlated
+3.52%
More

NNVC and

Correlation & Price change

A.I.dvisor indicates that over the last year, NNVC has been loosely correlated with MDGL. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if NNVC jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NNVC
1D Price
Change %
NNVC100%
+6.80%
MDGL - NNVC
34%
Loosely correlated
-1.79%
ZNTL - NNVC
34%
Loosely correlated
+10.29%
CGEM - NNVC
32%
Poorly correlated
+1.23%
TYRA - NNVC
32%
Poorly correlated
+6.32%
CYTK - NNVC
31%
Poorly correlated
+1.28%
More